Search

Search Constraints

You searched for: Author/Creator Keller, Birgit

Search Results

1. 015  Reduced risk of secondary progressive multiple sclerosis by treatment with clad- ribine tablets: CLARITY study analysis. Issue 6 (27th May 2022)

2. 016  Long-term disease stability in patients treated with cladribine tablets in CLARITY and CLARITY extension. Issue 6 (27th May 2022)

3. Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies. (January 2022)

4. Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS. Issue 4 (14th July 2022)

6. Efficacy and safety of eslicarbazepine acetate versus controlled‐release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double‐blind, randomized, parallel‐group, multicenter study. (25th January 2018)

8. Yersinia enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host cells. (20th March 2015)

9. Yersinia enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host cells. (20th March 2015)